Demetrix recently announced commercial production of a rare cannabinoid, along with a partnership with ingredient supplier Evonik. CosmeticsDesign spoke with Cynthia Bryant, chief business officer at Demetrix, about what the announcements mean for CBG...
The Vancouver-based ingredient maker—in partnership with Signum Biosciences—has completed studies on the efficacy and safety of it cannabigerol on human skin.
This month, Lygos CBx and MetaLabs announced a deal that has the US and Korea – based companies collaborating on shampoo and other products formulated with CBG.
Cannabinoid ingredients are increasingly popular in personal care. And with its engineered yeast and fermentation process, the biotech company Amyris is now equipped to manufacture cannabigerol, or CBG, commercially.
